Glucagon receptor agonism provides a mechanistic rationale for hepatic benefit, but liver-specific efficacy data is limited
This is a recurring theme in research-chemical quality: the label is not the molecule, and conclusions drawn from an uncharacterized preparation carry a large asterisk regardless of how careful the downstream experiment is
If you are considering peptides, or have a knee injury or condition, please seek personalised advice from your treating surgeon, GP, or another appropriately qualified health professional
Li et al., 2013), and others (Wang et al., 2013) have been described and praised for their intrinsic peroxidase-like activities in a variety of assays
Some patients may experience minimal weight change despite treatment
The grey market for tirzepatide has exploded